| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a48132fcc2f50a7107021f911f887cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-811 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 |
| filingDate |
1997-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5f1eed9943c3387faee8a09655be7f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763d9296056c88eaaf2bfb51f67efb32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb92fa774581691c83f26bad96fd5ac3 |
| publicationDate |
1999-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TR-199900764-T2 |
| titleOfInvention |
A hormonal composition consisting of an estrogen compound and a progestational compound. |
| abstract |
This invention relates to the field of therapeutic chemistry, and in particular to hormonal pharmaceutical techniques. More in detail, they are new pharmaceutical compositions that are composed of an estroprogestative combination in order to correct estrogenic disorders in natural or artificial menopause or to stop ovulation in women when their ovulation is active. In addition, the invention relates to an estroprogestative mixture in which the estrogenic substance and the progestative substance are co-administered and that can be administered with or without interruption. Another subject of this invention is a preparation process for these new estroprogestative pharmaceutical compositions. |
| priorityDate |
1996-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |